Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson’s disease: a systematic review and meta-analysis

Diagnostic performance of artificial intelligence-assisted PET imaging for Parkinson’s disease: a systematic review and meta-analysis

Abstract Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the diagnosis of Parkinson’s disease (PD). We aim to systematically review the diagnostic accuracy of AI-assisted PET in detecting PD. The Ovid MEDLINE, Ovid Embase, Web of Science, and IEEE Xplore databas...

Full description

Bibliographic Details
Main Authors:	Jing Wang, Le Xue, Jiehui Jiang, Fengtao Liu, Ping Wu, Jiaying Lu, Huiwei Zhang, Weiqi Bao, Qian Xu, Zizhao Ju, Li Chen, Fangyang Jiao, Huamei Lin, Jingjie Ge, Chuantao Zuo, Mei Tian
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-01-01
Series:	npj Digital Medicine
Online Access:	https://doi.org/10.1038/s41746-024-01012-z

Similar Items

The Parkinson’s Disease Progression Neuroimaging Initiative
by: Shiyi Zhu, et al.
Published: (2021-01-01)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
by: Fangyang Jiao, et al.
Published: (2023-02-01)

In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer’s Disease: A <sup>18</sup>F-Florzolotau Study
by: Zizhao Ju, et al.
Published: (2022-10-01)

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
by: Danyan Chen, et al.
Published: (2019-04-01)

Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism
by: Yujie Yang, et al.
Published: (2023-12-01)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
by: Jiaying Lu, et al.
Published: (2023-06-01)

Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control
by: Ting Shen, et al.
Published: (2019-04-01)

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
by: Jingjie Ge, et al.
Published: (2020-10-01)

Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control
by: Danyan Chen, et al.
Published: (2018-01-01)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
by: Hucheng Zhou, et al.
Published: (2019-01-01)

Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [18F]Florzolotau PET imaging and subtype/stage inference algorithmResearch in context
by: Jimin Hong, et al.
Published: (2023-11-01)

Radiomics-Guided Deep Learning Networks Classify Differential Diagnosis of Parkinsonism
by: Ronghua Ling, et al.
Published: (2024-07-01)

Improved interpretation of 18F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier
by: Jiaying Lu, et al.
Published: (2023-08-01)

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
by: Yilin Tang, et al.
Published: (2016-01-01)

Does the Personality of Patients with Parkinson’s Disease Affect the Decision to Perform Deep Brain Stimulation Surgery? A Cross-Sectional Study in a Chinese Cohort
by: Wei Lin, et al.
Published: (2021-01-01)

Corrigendum to “Does the Personality of Patients with Parkinson’s Disease Affect the Decision to Perform Deep Brain Stimulation Surgery? A Cross-Sectional Study in a Chinese Cohort”
by: Wei Lin, et al.
Published: (2021-01-01)

Frequency-Dependent Relationship Between Resting-State fMRI and Glucose Metabolism in the Elderly
by: Fangyang Jiao, et al.
Published: (2019-05-01)

Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism
by: Naba Jawad Houssein, et al.
Published: (2023-08-01)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
by: Ting Shen MsD, et al.
Published: (2019-09-01)

Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson’s disease
by: Xiu-Lin Liu, et al.
Published: (2022-07-01)

PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F]DPA714
by: Wei Hu, et al.
Published: (2020-09-01)

Corrigendum: Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson's disease
by: Xiu-Lin Liu, et al.
Published: (2022-09-01)

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
by: Min Wang, et al.
Published: (2020-01-01)

Preserved caudate function in young-onset patients with Parkinson’s disease: a dual-tracer PET imaging study
by: Yu-jie Yang, et al.
Published: (2019-05-01)

Diagnostic metabolomic profiling of Parkinson's disease biospecimens
by: Peter A. LeWitt, et al.
Published: (2023-02-01)

Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson’s Disease Using Quantitative Indices of <sup>18</sup>F-FP-CIT PET/CT
by: Miju Cheon, et al.
Published: (2022-06-01)

Differences in Striatal Metabolism in [<sup>18</sup>F]FDG PET in Parkinson’s Disease and Atypical Parkinsonism
by: Alexander P. Seiffert, et al.
Published: (2022-12-01)

Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
by: Minyoung Oh, et al.
Published: (2023-09-01)

Detection of individual brain tau deposition in Alzheimer's disease based on latent feature-enhanced generative adversarial network
by: Jiehui Jiang, et al.
Published: (2024-05-01)

The diagnostic and prognostic value of tau‐PET in amnestic MCI with different FDG‐PET subtypes
by: Cecilia Boccalini, et al.
Published: (2024-05-01)

Workup of Parkinson's Disease, Parkinson Plus, Lewy Body, and Alzheimer's Dementia Should Include SPECT, PET and Genetics
by: Josef Finsterer
Published: (2024-11-01)

11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
by: Xiaolin Sun, et al.
Published: (2024-04-01)

Quantifying Lenition as a Diagnostic Marker for Parkinson’s Disease and Atypical Parkinsonism
by: Ratree Wayland, et al.
Published: (2024-11-01)

The value of 18F⁃FDG PET in the diagnosis and differential diagnosis of Parkinson's disease and multiple system atrophy with parkinsonism⁃predominant
by: DU Xiao‐xiao, et al.
Published: (2024-12-01)

Image Fusion for medical image diagnostic : CT-PET /
by: Nur Aini Fadzilah Mohammad, 1990-, author, et al.
Published: (2013)

Image Fusion for medical image diagnostic : CT-PET /
by: Nur Aini Fadzilah Mohammad, 1990-, author, et al.
Published: (2013)

Diagnostic Value of PET/MR with DWI for Burkitt Lymphoma
by: Chiara Giraudo, et al.
Published: (2021-10-01)

The Impact of PET/MRI Fusion on the Diagnostic Imaging Industry
by: Shrooq Aldahery
Published: (2023-09-01)

Analysis of Antioxidant Capacity of Chromones in Saposhnikoviae Radix Obtained by Ultrasonic-Assisted Deep Eutectic Solvents Extraction
by: Xianwen Yue, et al.
Published: (2020-01-01)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
by: Hossein Moein Taghavi, et al.
Published: (2024-10-01)